THIRD DAY

SATURDAY • OCTOBER 5, 2024

Session VIII – Short Talks – Selected from Abstract
Chair: Dr. Julie Constanzo
Sponsored by TBD

8:30 am – 8:45 am: Synergistic Effects of Pembrolizumab and Radiation Therapy in Early-Stage Triple-Negative Breast Cancer: Insights from the P-RAD Clinical Trial and Preclinical Autochthonous Murine Model
Sierra McDonald, PhD
University of North Carolina School of Medicine, North Carolina, US

8:45 am – 9:00 am: ART1: A hidden player in radiotherapy-immunotherapy resistance
Erik Wennerberg
Institute for Cancer Research, London, UK

Session IX – Novel approaches
Chairs: Dr. Encouse Golden, Diego Sialer
Sponsored by TBD

9:00 am – 9:30 am: Relative Immunological Effectiveness of Carbon Ion Radiation Therapy
Chandan Guha
Albert Einstein College of Medicine, New York, USA             

9:30 am – 10:00 am: Approach to Radiation Therapy in the Era of Immunotherapy
Aisha Hasan and Rosa Martin-Perez
Johnson & Johnson, USA

10:00 am – 10:30 pm: Dendritic Cells Accelerate CAR T Cells Through Chimeric Synapses in Irradiated Tumors
Jalal Ahmed
Icahn School Of Medicine at Mount Sinai, New York, USA

10:30 am – 11:00 am
Coffee break

PANEL DISCUSSION
Sponsored by TBD

11:00 am – 12:00 pm
Silvia C. Formenti, MD
Weill Cornell Medical College, New York, NY, USA

Eric Deutsch, MD
Gustave Roussy Cancer Center, Paris, France       

Philippe Szapary, MD MSCE
Johnson & Johnson, USA

Sebastien Paris, MD
Nanobiotix, USA

Howard Kaufman, MD
Ankyra Therapeutics, USA

Dhan Chand, MD
Agenus Bio, USA

CONCLUDING REMARKS
12:00 pm - 12:15 pm
Eric Deutsch, MD
Gustave Roussy Cancer Center, Paris, France

12:15 pm
End of Day 3